첫 페이지 News 본문

According to the Tianyancha App, on September 18th, Johnson&Johnson (China) Investment Co., Ltd. underwent a business change, with Song Weiqun stepping down as the legal representative and chairman, and being succeeded by ZHOU MINTAO.
Johnson&Johnson (China) Investment Co., Ltd. was established in May 1998 with a registered capital of approximately 169 million US dollars. Its business scope includes wholesale and retail of drugs, as well as import and export of drugs. It is jointly owned by Johnson&Johnson of the United States and Janssen Pharmaceuticals of Belgium. In April of this year, Johnson&Johnson announced that Will Song, Chairman of the China region and President of Johnson&Johnson Medical Technology China, had submitted his resignation to Johnson&Johnson.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
您需要登录后才可以回帖 登录 | Sign Up

本版积分规则

芊芊551 注册会员
  • Follow

    0

  • Following

    0

  • Articles

    44